Baylor College of Medicine receives $822,000 in Komen grants Sep 22, 2015 Researchers from the NCI-Comprehensive Designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine have received over $822,000 in grant funding from Susan G. Komen for four new projects in breast cancer research.
New microsurgery for early stage GI cancer patients Sep 17, 2015 A new endoscopic microsurgery known as endoscopic submucosal dissection (ESD), offers a non-invasive approach to removing small gastrointestinal tumors by removing them in layers.
Baylor research team joins NCI consortium aimed at finding new therapies for children’s cancer Sep 15, 2015 Baylor one of five groups to receive a National Cancer Institute grant to address key challenges in developing new therapies for children with cancer.
Baylor College of Medicine receives grant to study experimental immunotherapy in HPV-related throat cancer Sep 14, 2015 Baylor researchers receive $1.1 million grant from the U.S. Food and Drug Administration to advance clinical studies of an experimental immunotherapy for HPV related throat cancer.
Cycle for a cure Sep 9, 2015 Baylor teaming up with Ovarian Cancer Research Fund for Sept. 19 Ovarian Cycle Houston event.
Curley awarded $9 million grant to study radiofrequency treatments for pancreatic and liver cancers Sep 9, 2015 Dr. Steven Curley and his research team will study radiofrequency energy to treat cancer alone or in combination with drugs and treatment-enhancing agents such as nanoparticles.
Disruption of a crucial cellular machine may kill the engine of deadly cancers Sep 2, 2015 Baylor College of Medicine study finds that inhibition of the spliceosome using a new drug kills tumor cells but leaves noncancerous tissues unaffected in mouse models.
Electronic trigger reduces delays in evaluation for cancer diagnosis Aug 24, 2015 Electronic triggers designed to search for key data were able to identify and reduce follow-up delays for patients being evaluated for a diagnosis of colon or prostate cancer.
Super-stimulation makes SRCs cancer cell killers Aug 10, 2015 Too much of a bad thing could have a positive effect – especially when there is too much of a master cell regulator and a small molecule that can make it a cancer fighter, said Baylor College of Medicine researchers.
Baylor’s Dan L Duncan Cancer Center receives highest National Cancer Institute designation – Comprehensive status Jul 30, 2015 The National Cancer Institute has awarded the Dan L Duncan Cancer Center at Baylor College of Medicine the prestigious designation of a Comprehensive Cancer Center.